NCT01325545

Brief Summary

About one-third of patients with stroke have no documented cause for the cerebrovascular event (known as cryptogenic strokes). Atrial fibrillation is a common cause of stroke, but when transient (paroxysmal) it may remain undiagnosed. Recent data suggest that occult paroxysmal atrial fibrillation may be identified in patients with cryptogenic strokes using prolonged ambulatory cardiac rhythm monitors. The investigators designed this study pursuing the following goals:

  1. 1.To determine the prevalence of occult paroxysmal atrial fibrillation in patients with cryptogenic stroke using long-term mobile cardiac outpatient telemetry.
  2. 2.To compare this prevalence to that found in a control group with stroke of known, non-cardioembolic cause.
  3. 3.To look for clinical, laboratory, echocardiographic, and imaging data that serve as risk factors for occult paroxysmal atrial fibrillation in patients with cryptogenic stroke.
  4. 4.To examine the utility of mobile cardiac outpatient telemetry, a relatively new diagnostic tool, in the evaluation of patients with cryptogenic stroke.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
132

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2009

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

March 28, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 29, 2011

Completed
Last Updated

December 23, 2011

Status Verified

December 1, 2011

Enrollment Period

1.9 years

First QC Date

March 28, 2011

Last Update Submit

December 21, 2011

Conditions

Keywords

StrokeAtrial Fibrillation

Outcome Measures

Primary Outcomes (1)

  • Detection of Atrial Fibrillation

    Documented presence of atrial fibrillation detected by the monitoring device and independently confirmed by a board-certified cardiologist

    21 days

Secondary Outcomes (5)

  • Time to first episode of atrial fibrillation

    Within monitoring period (3 weeks)

  • Atrial Fibrillation Load

    Within monitoring period (3 weeks)

  • Adverse events related to mobile cardiac monitoring

    21 days

  • Symptomatic status of episode of atrial fibrillation

    21 days

  • Longest duration of episode of atrial fibrillation

    21 days

Study Arms (2)

Cryptogenic stroke

Patients with stroke of unknown cause after comprehensive conventional evaluation

Other: Mobile cardiac rhythm monitoring

Stroke of known cause

Patients with stroke of known cause determined by comprehensive conventional evaluation

Other: Mobile cardiac rhythm monitoring

Interventions

Continuous ambulatory cardiac rhythm monitoring using the CardioNet MCOT device

Cryptogenic strokeStroke of known cause

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with stroke or TIA confirmed by a vascular neurologist within previous 3 months with complete evaluation for stroke causes according to current standards.

You may qualify if:

  • Stroke or TIA within previous 3 months
  • Stroke work up including: EKG, serum lipids, serum TSH, TTE or TEE, brain CT and/or MRI, Vascular Evaluation of head and neck using any combination of ultrasound, MRA, CTA, and conventional angiography

You may not qualify if:

  • Documented history of atrial fibrillation or flutter
  • PFO closure planned before conclusion of the monitoring period
  • Incomplete stroke work up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Baturova MA, Sheldon SH, Carlson J, Brady PA, Lin G, Rabinstein AA, Friedman PA, Platonov PG. Electrocardiographic and Echocardiographic predictors of paroxysmal atrial fibrillation detected after ischemic stroke. BMC Cardiovasc Disord. 2016 Nov 3;16(1):209. doi: 10.1186/s12872-016-0384-2.

MeSH Terms

Conditions

StrokeAtrial Fibrillation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesArrhythmias, CardiacHeart DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Neurology

Study Record Dates

First Submitted

March 28, 2011

First Posted

March 29, 2011

Study Start

April 1, 2009

Primary Completion

March 1, 2011

Study Completion

March 1, 2011

Last Updated

December 23, 2011

Record last verified: 2011-12